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adial Versus Femoral Approach for Percutaneous
oronary Diagnostic and Interventional Procedures
ystematic Overview and Meta-Analysis of Randomized Trials
ierfrancesco Agostoni, MD,* Giuseppe G. L. Biondi-Zoccai, MD,† M. Luisa De Benedictis, MD,*
tefano Rigattieri, MD,† Marco Turri, MD,* Maurizio Anselmi, MD,* Corrado Vassanelli, MD,‡
iero Zardini, MD,* Yves Louvard, MD,§ Martial Hamon, MD
erona, Rome, and Novara, Italy; and Massy and Caen, France
OBJECTIVES We sought to compare, through a meta-analytic process, the transradial and transfemoral
approaches for coronary procedures in terms of clinical and procedural outcomes.
BACKGROUND The radial approach has been increasingly used as an alternative to femoral access. Several
trials have compared these two approaches, with inconclusive results.
METHODS The MEDLINE, CENTRAL, and conference proceedings from major cardiologic associ-
ations were searched. Random-effect odds ratios (ORs) for failure of the procedure (crossover
to different entry site or impossibility to perform the planned procedure), entry site
complications (major hematoma, vascular surgery, or arteriovenous fistula), and major adverse
cardiovascular events (MACE), defined as death, myocardial infarction, emergency revascu-
larization, or stroke, were computed.
RESULTS Twelve randomized trials (n  3,224) were included in the analysis. The risk of MACE was
similar for the radial versus femoral approach (OR 0.92, 95% confidence interval [CI] 0.57
to 1.48; p  0.7). Instead, radial access was associated with a significantly lower rate of entry
site complications (OR 0.20, 95% CI 0.09 to 0.42; p 0.0001), even if at the price of a higher
rate of procedural failure (OR 3.30, 95% CI 1.63 to 6.71; p  0.001).
CONCLUSIONS The radial approach for coronary procedures appears as a safe alternative to femoral access.
Moreover, radial access virtually eliminates local vascular complications, thanks to a
time-sparing hemostasis technique. However, gaining radial access requires higher technical
skills, thus yielding an overall lower success rate. Nonetheless, a clear ongoing trend toward
equalization of the two procedures, in terms of procedural success, is evident through the
years, probably due to technologic progress of materials and increased operator
experience. (J Am Coll Cardiol 2004;44:349–56) © 2004 by the American College of
Cardiology Foundationl
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che transradial approach for coronary procedures has
ained progressive acceptance since its first introduction by
ampeau in 1989 (1) for diagnostic coronary angiography
nd its improvement by Kiemeneij and Laarman (2) for
ercutaneous transluminal coronary angioplasty (PTCA)
nd stenting. Subsequently, a widespread diffusion of coro-
ary procedures via the radial artery took place in America
3,4), Asia (5,6), and Europe (7,8).
Indeed, transradial access has been shown by some
uthors to have several advantages over transfemoral ap-
roach. The radial artery is easily compressible, thus bleed-
ng is controllable and hemorrhagic complications are sig-
ificantly reduced. Moreover, no major nerves or veins are
From the *Department of Biomedical and Surgical Sciences, Section of Cardiology,
niversity of Verona, Verona, Italy; †Institute of Cardiology, Catholic University,
ome, Italy; ‡Institute of Cardiology, Piemonte Orientale University, Novara, Italy;
Institut Hospitalier Jacques Cartier—ICPS, Massy, France; and Service des
aladies du Coeur et Vaisseaux, Centre Hospitalier Universitaire, Caen, France. This
tudy was presented as an abstract at the 2003 Congress of the Italian Society of
nvasive Cardiology, Genoa, Italy, October 15–18, 2003. This meta-analysis is part
f an ongoing training project of the Center for Overview, Meta-analysis and
vidence-based medicine Training (COMET), based in Verona, Italy.
Manuscript received February 9, 2004; revised manuscript received March 17,s004, accepted April 6, 2004.ocated near the artery, minimizing the risk of injury of
hese structures. Finally, postprocedural bed rest is not
equired, permitting immediate ambulation, more comfort,
nd early discharge. This last advantage has shown to
mprove quality of life for patients (9) and to reduce the
osts of hospitalization (9,10). Despite this large amount of
enefits, the transradial approach is more demanding than
ransfemoral access and requires a longer learning curve for
he operator (11,12). Furthermore, it does not give the
ossibility to use other devices such as a temporary pace-
aker or intra-aortic balloon pump and to perform coronary
nterventions requiring 8-F catheters. Moreover, it is not
lways feasible, because some patients may have an anom-
lous palmar arch that does not provide sufficient blood
upply to the hand in case of thrombotic or traumatic
cclusion of the radial artery. Indeed, several authors have
dvocated, before the procedure, the mandatory assessment
f adequacy of collateral blood flow from the ulnar artery by
eans of the Allen test (13), even if some authorities have
ecently reported no ischemic complications from radial
atheterization, irrespective of any evaluation of blood
upply to the hand (Y. Louvard and T. Saito, personal
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Radial Versus Femoral Coronary Procedures: Meta-Analysis July 21, 2004:349–56ommunications, 2004). Finally, entry site failure is not a
emote possibility, often because of anatomic variation and
ortuosity of the radial artery (14).
Conversely, the femoral approach is still considered by
any as the standard technique because of its optimal
atheter control, uncommon thrombotic complications, and
mmediate access to large-diameter devices. Nonetheless,
uch advantages are partially offset by bleeding complica-
ions, often mandating long bed rest, and the frequent
ccurrence of peripheral arterial disease, which limit trans-
emoral cardiac catheterization. The choice of vascular
ccess site is thus in many centers more a matter of
radition, opinion, and expertise than an evidence-based
ecision.
Several randomized trials have been undertaken to com-
are the transradial and transfemoral approach, but the
ajority of them carefully selected a small number of
omogeneous patients, were underpowered to detect differ-
nces in major adverse events, and yielded somewhat con-
icting and inconclusive results. As systematic overviews
ay thoroughly assess available sources of clinical evidence,
chieving more precise effect estimates with greater statis-
ical power (15), we performed a meta-analysis of all trials
irectly comparing these two vascular access site techniques.
ETHODS
earch strategy. The MEDLINE and CENTRAL were
earched by a trained investigator (Dr. Agostoni) for eligible
tudies published between January 1989 and August 2003.
n additional search involved mRCT. Search key words
ncluded: “random*,” “transradial,” “radial access,” “radial
pproach,” and “coronary.” Various combinations of these
erms were used depending on the requirements of the data
ase. No language restriction was used. Conference pro-
eedings from the 2000 to 2003 American College of
ardiology, American Heart Association, European Society
f Cardiology, and Transcatheter Cardiovascular Therapeu-
ics annual scientific sessions were also hand-searched.
ajor reviews regarding the radial approach for coronary
rocedures were systematically searched. Cross-references
nd quoted papers were checked, and experts were contacted
o identify other relevant trials.
election criteria. Inclusion criteria for retrieved studies
ere: 1) a controlled comparison of the radial versus femoral
Abbreviations and Acronyms
CABG  coronary artery bypass graft surgery
CI  confidence interval
MACE  major adverse cardiovascular events
OR  odds ratio
PCI  percutaneous coronary procedure
PTCA  percutaneous transluminal coronary angioplasty
SMD  standardized mean difference
WMD  weighted mean differencepproach for percutaneous coronary angiography or inter- aention (either PTCA or stenting); 2) randomized treat-
ent allocation; and 3) intention-to-treat analysis. Exclu-
ion criteria were: 1) incomplete follow-up (80%); and 2)
lack of clear and reproducible results.
ata abstraction and validity assessment. Data abstrac-
ion was independently performed by two unblinded review-
rs (Drs. Agostoni and De Benedictis) on prespecified
tructure collection forms. There were no divergences in
ata collection. The study quality was evaluated by the same
wo investigators according to a score, modified from Jadad
t al. (16) and Biondi-Zoccai et al. (17), expressed on an
rdinal scale, allocating 1 point for the presence of each of
he following: 1) statement of objectives; 2) explicit inclu-
ion and exclusion criteria; 3) description of interventions;
) objective means of follow-up; 5) description of adverse
vents; 6) power analysis; 7) description of statistical meth-
ds; 8) multicenter design; 9) discussion of withdrawals; and
0) details on medical therapy (e.g., antithrombotic regi-
ens) during and after coronary procedures. Divergencies
ere resolved by consensus.
tudy characteristics. The primary clinical outcomes of
nterest, evaluated at the longest available follow-up, were 1)
ajor adverse cardiovascular events (MACE), including
eath, myocardial infarction, emergency percutaneous cor-
nary intervention (PCI), or coronary artery bypass graft
urgery (CABG) and stroke; 2) entry site complications,
ncluding major bleedings (requiring prolonged hospitaliza-
ion, surgical intervention, or blood transfusion), pseudo-
neurysms (requiring surgical or percutaneous intervention),
rteriovenous fistulas, limb ischemia resulting in the need
or vascular surgery, and nerve damage; and 3) procedural
ailure, defined as the need to puncture a second access site
ue to any procedural failure (inability to puncture the entry
ite artery, failure to cannulate the coronary artery, impos-
ibility to perform the planned PTCA or stenting of the
oronary artery) or due to a major access site complication.
Secondary procedural outcomes, pooled from individual
tudies when available, were: procedural time (in minutes),
uoroscopy time (in minutes), length of hospital stay (in
ays), and overall hospital costs (in the currency of the
ountry where the trial was performed).
ata analysis and synthesis. Statistical analysis was per-
ormed using the Review Manager 4.1.1 freeware package
18). Review Manager is a comprehensive statistical and
eviewing program, developed and maintained by the Co-
hrane Collaboration, which includes ad hoc statistical tools
or pooled effect estimate calculations, according to several
ethods (19). Dichotomous variables are reported as pro-
ortions and percentages, and continuous variables as mean
alues. Binary outcomes from individual studies were to be
ombined with both the Mantel-Haenzel fixed effect model
nd the DerSimonian and Laird random effects model (19),
hereas continuous variables were compared using the
erSimonian and Laird random effects model (19). The
dds ratio (OR) and 95% confidence interval (CI) were used
s summary statistics for the comparison of dichotomous
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July 21, 2004:349–56 Radial Versus Femoral Coronary Procedures: Meta-Analysisariables between the radial and femoral approach. The
eighted mean difference (WMD) and 95% CI were used
or continuous variables with the same unit of measure,
hereas the standardized mean difference (SMD) was used
or continuous variables with a different unit of measure.
eported values were two-tailed, and hypothesis testing
esults were considered statistically significant at p  0.05.
ensitivity and subgroup analyses were performed using the
ollowing categories: 1) diagnostic catheterizations (studies
ith 50% of the patients undergoing PCI were included
n this group) versus interventional procedures; 2) elective
ersus acute settings; 3) higher than median and median
ersus lower than median quality studies; and 4) after
xclusion of studies published as abstracts. Formal Cochran
chi-square tests were performed to investigate heteroge-
eity between trials (respective scores, degrees of freedom,
nd p values are reported [19]). This study was performed
ccording to established methods (17) and in compliance
ith the Quality of Reporting of Meta-Analyses
QUORUM) guidelines (20).
ESULTS
earch results and study selection. We found more than
70 citations in MEDLINE and other data sources. Most
f them were editorials, reviews, letters, or articles regarding
ther aspects of the radial approach (anti-spasm therapy,
ocal anesthesia, comparison of different sheaths) or other
ngiographic studies (carotid, cerebral, or renal). There were
4 observational studies investigating the feasibility and
afety of the radial approach in a series of patients. More-
ver, we found 15 studies comparing the radial and femoral
pproach in a nonrandomized fashion (historical controls,
ase-control studies, and allocation according to operator’s
bility to perform transradial procedures). We finally iden-
ified 14 eligible, randomized clinical trials, and complete
able 1. Description of Studies Included in the Meta-Analysis
Study (Ref. #)
Years of
Enrollment
Principal
Investigator Location
rinfield et al. (4) 1994–1995 L. Grinfield Argentina
ann et al. (10) 1994–1995 T. Mann U.S.
CCESS (24) 1993–1995 F. Kiemeneij Netherlands
RAFE Stent (23) 1994–1995 E. Benit Belgium
ann et al. (25) 1997 T. Mann U.S.
ooper et al. (9) 1996–1997 C. J. Cooper U.S.
onse´gu et al. (26) 1999 J. Monse´gu France
ARAFE (27) 1998–1999 Y. Louvard France
orge et al. (28) 2001* G. Gorge Germany
oriyama et al. (29) 2002 Y. Moriyama Japan
EMPURA (30) 1999–2001 S. Saito Japan
CTO-PLUS (31) 2003* M. Hamon,
Y. Louvard
France, Eng
Year of publication.
MACE  major adverse cardiovascular events.rticles were retrieved when applicable and checked for ompliance with inclusion and exclusion criteria. Data
bstraction was performed and individual researchers con-
acted in case of incomplete reporting. We excluded two
tudies (21,22), published as abstracts, because the authors
id not provide complete results and the data present in the
bstracts were insufficient to be correctly analyzed.
tudy and patient characteristics. The 12 studies included
n the final analysis randomized 3,224 patients: 1,668 to the
ransradial and 1,556 to the transfemoral approach
4,9,10,23–31). Five studies (4,26,28,29,31) were published
nly as abstracts, but they were included in the analysis
ecause of the importance of the so-called “gray” literature
32) (Table 1).
Seven studies (4,9,26–29,31) enrolled 2,069 subjects to
erform only diagnostic catheterization, whereas five studies
10,23–25,30) involved 1,155 patients for PCI, two of
hich were done in an urgent setting, involving acute
oronary syndromes (25) or acute myocardial infarction
30). The mean age was 65 years. On average, males
ccounted for 70.8% of subjects. In the majority of the
tudies, the arterial access was obtained with a 6-F intro-
ucer, apart from one in which a 7-F sheath was used in
bout 74% of patients in the femoral group (25), one in
hich both 5-F or 6-F introducers were used in the two
roups but the size was selected before knowledge of the
andomized access site (10), two in which a 5-F (27) or 4-F
28) sheath was used in both groups, one in which a 4-F
emoral and 5-F radial sheath was used (26), and one in
hich a 4-F, 5-F, or 6-F catheter was used (28). Heparin
as administered intravenously in all patients undergoing
ransradial catheterization, both diagnostic and interven-
ional, whereas it was administered in the transfemoral
pproach subjects only if PCI was planned. Glycoprotein
Ib/IIIa inhibitors and thrombolytic agents were used only
n two studies (25,31) and in a small number of patients (n
No. of
Patients Primary End Point Follow-Up
279 Entry site failure, procedural time In-hospital
152 Procedural outcome In-hospital
600 Entry site failure and complications,
procedural outcome
1 month
112 Entry site complication, hospitalization
time
1 month
142 Procedural outcome In-hospital
200 Quality of life, costs 1 week
379 Procedural outcome In-hospital
210 Procedural outcome, time,
complications, hospitalization time
In-hospital
430 Procedural time, complications In-hospital
200 Procedural time In-hospital
149 MACE 9 months
371 Entry site complications In-hospitalland62 and n  41, respectively). All the studies presented
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Radial Versus Femoral Coronary Procedures: Meta-Analysis July 21, 2004:349–56ata on the in-hospital follow-up, apart from two in which
ollow-up data were recorded for one month (23,24) and
ne for nine months (30) (Table 2).
linical results. The results of the meta-analysis are pre-
ented according to the more robust and conservative
andom effects method, even if similar results were obtained
sing a fixed effects method. In terms of MACE (Fig. 1),
he transradial and transfemoral approach yielded similar
esults, with 35 (2.1%) of 1,668 and 38 (2.4%) of 556 events
n the two groups, respectively (OR 0.92, 95% CI 0.57 to
.68; p  0.7). The transradial approach was instead signifi-
antly superior to femoral access in terms of the risk of entry
ite complications (5 [0.3%] of 1,472 vs. 39 [2.8%] of 1,373
ubjects; OR 0.20, 95% CI 0.09 to 0.42; p 0.0001) (Fig. 2).
onversely, transradial access was associated with a signifi-
antly higher number of procedural failures in comparison to
emoral access (107 [7.2%] of 1,472 vs. 33 [2.4%] of 1,373
ubjects; OR 3.30, 95% CI 1.63 to 6.71; p  0.001) (Fig. 3).
able 2. Description of Populations and Procedures of Included
Study (Ref. #)
Mean
Age
(yrs)
Males
(%)
Antithrombotic
Treatment
Experien
Radia
Operato
rinfield et al. (4) 63 73 NA No
ann et al. (10) 62 71 H, ASA Yes
CCESS (24) 61 72 H, ASA Yes
RAFE Stent (23) 58 100 H, WA, ASA No
ann et al. (25) 62 67 H, ASA, TP Yes
ooper et al. (9) 60 69 H (only radial) Some
onse´gu et al. (26) NA NA NA Some
ARAFE (27) 62 78 H, ASA, TP Yes
orge et al. (28) NA NA NA No
oriyama et al. (29) 67 68 NA Some
EMPURA (30) 67 82 H, ASA, TP Yes
CTO-PLUS (31) 83 53 H, ASA, TP Yes
Defined as operators with an elevated number of procedures performed via the radial a
pproach, as deduced from other published data. †Quality score was expressed on an
ASA  aspirin; F  French; H  heparin; NA  not available; PCI  percutaFigure 1. Overall risk of major adverse cardiovascular events (MACE). CIdditional analysis. Heterogeneity testing did not show
ny significant departure from the assumption of statistical
omogeneity for MACE and entry site complications.
egarding procedural failure, however, the heterogeneity
est appeared statistically significant (chi-square  18.71, df
10, p  0.044), probably due to an initial learning curve
y cardiologists employing the radial technique, thus tem-
orarily favoring the femoral technique, followed by a
rogressive equalization in technical skills for both the radial
nd femoral approaches through the years.
The OR calculations were also performed according to a
xed effects model, yielding similar results with regard to
oth the direction and magnitude of overall effects, thus
onfirming the robustness of the results.
Stratification and sensitivity analysis excluding studies
ublished only as abstracts showed similar results to those of
he comprehensive analysis. Findings were also comparable
fter prespecified stratification in higher than median and
es
Sheath Size
Diagnostic
Catheterization
(%)
PCI
Quality†
Elective
(%)
Urgent
(%)
NA 100 — — 1
6-F — 100 — 7
6-F — 100 — 9
6-F — 100 — 6
6/7-F — — 100 7
5/6-F 100 — — 9
4/5-F 100 — — 1
5-F 57 43 — 7
4/5/6-F 74 26 1
4-F 100 — — 4
6-F — — 100 9
NA 51 49 — 7
s stated in this report, or as operators known to use the radial artery as the first-choice
al scale, ranging from 1 to 10 (see text for details).
coronary interventions; TP  ticlopidine; WA  warfarin.Studi
ced
l
rs*
rtery, a
ordin
neous confidence interval; OR  odds ratio; year  year of publication.
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July 21, 2004:349–56 Radial Versus Femoral Coronary Procedures: Meta-Analysisedian versus lower than median quality studies, diagnostic
ersus interventional procedures, and elective versus urgent
CI (Table 3).
rocedural results. Secondary procedural outcomes were
verall strongly heterogeneous, mainly due to the different
linical settings in which the procedures were performed.
urthermore, the definition of procedural time, which was
eported in 11 trials (3,082 patients), varied widely among
he studies, ranging from the arterial time to the total
atheterization laboratory time (included sheath removal
ime). This added further heterogeneity to this analysis.
owever, in the transradial group, the mean procedural
ime was 35 min, whereas in the transfemoral group, it was
3.8 min. No significant difference was present (WMD
.62, 95% CI 5.10 to 8.34). The fluoroscopy time, a more
eliable marker of procedural complexity, was assessed in 10
tudies (2,970 patients). It was significantly shorter in the
Figure 2. Overall risk of entry site complications. CI  coFigure 3. Overall risk of procedural failure. CI  confidenceemoral approach group (7.8 min) as compared with the
adial group (8.9 min; WMD 1.05, 95% CI 0.51 to 1.60; p
0.001). Regarding length of stay, advantages of the radial
pproach were evident among all the eight studies (1,844
atients) that evaluated this parameter. The mean hospital
tay was 1.8 days in the radial group versus 2.4 days in the
emoral group (WMD 0.55, 95% CI 0.82 to 0.29; p
0.001). Finally, total hospital charge, assessed in five
tudies (853 patients), was lower in the transradial approach
s compared with the transfemoral approach (SMD 1.43,
5% CI 2.30 to 0.55; p  0.001).
ISCUSSION
he present meta-analysis shows that the transradial ap-
roach for coronary procedures is a highly safe and effective
echnique for both transcatheter diagnostic and therapeutic
ce interval; OR  odds ratio; year  year of publication.interval; OR  odds ratio; year  year of publication.
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Radial Versus Femoral Coronary Procedures: Meta-Analysis July 21, 2004:349–56rocedures, yielding similar rates of MACE in comparison
o the standard transfemoral access. Furthermore, the radial
pproach virtually abolishes entry site complications, as
ndeed only five local complications were found in 1,472
atients, in comparison to significantly higher rates of local
ascular complications in patients undergoing transfemoral
atheterization. Despite these advantages, radial vascular
ccess is still more challenging, in terms of feasibility and
echnical success in comparison to transfemoral access,
ecause of a higher proportion of procedural failures,
pecifically 7.2% versus 2.4%. Overall, the results of this
eta-analysis appear quite robust in the light of the lack of
eterogeneity among trials for MACE and local complica-
ions, as well as coherence between comprehensive and
ubgroup analyses.
imitations and advantages of transradial approach. Not-
ithstanding a higher number of procedural failures, an
vident trend toward equalization among the two tech-
iques in terms of feasibility is clearly present through the
ears. Actually, there are several reasons underlying a
rocedural failure. First, there could be an inability to
uccessfully puncture the radial artery, mostly because of
perator skill, vessel tortuosity, or persistent arterial spasm.
econd, it may be possible to fail to cannulate the coronary
stia due to difficulty in rotating and manipulating the
atheters. Finally, an interventional procedure could fail
ecause of inadequate catheter support or an inability to
rack the device in the correct place. All of these problems,
learly present in the early and pioneering trials of the
990s, were far less common in the later studies. This
ndeed is the most probable explanation for the statistically
ignificant heterogeneity present in the procedural failure
nalysis. Indeed, when dividing the studies in two subgroups
ccording to the year of publication (before and after 1999),
eterogeneity was no longer present (chi-square  4.20, df
4, p  0.38 for older studies; chi-square  2.83, df  5,
 0.73 for recent studies), and more recent trials showed
o significant difference in terms of procedural failure
etween radial and femoral access (32 [3.9%] of 828 vs. 21
2.9%] of 732 subjects, respectively; OR 1.39, 95% CI 0.78
o 2.47; p  0.3), whereas a strong difference was present in
he older trials (75 [11.6%] of 644 vs. 12 [1.9%] of 641
ubjects, respectively; OR 6.02, 95% CI 3.07 to 11.79; p 
.0001). The relatively high number of femoral failures in
able 3. Subgroup and Sensitivity Analyses
Subgroup or Statistical Model
for Sensitivity Analysis
No. of Studies
(Included Patients)
verall using fixed effect 12 (3,224) 0.
iagnostic catheterization studies 7 (2,069) 0.
CI studies 5 (1,155) 1.
igh-quality studies 7 (1,824) 0.
ow-quality studies 5 (1,400) 0.
ublished studies 7 (1,565) 1.
I  confidence interval; MACE  major adverse cardiovascular events; OR  odhe first subgroup is explained by the inclusion of theCTO-PLUS trial (31), which selected a very challenging
opulation of patients—all older than 80 years. In this trial,
he percentage of failures was similar but elevated with both
pproaches: 20 (10.6%) of 188 subjects in the radial group
nd 17 (9.3%) of 183 in the femoral group. In fact,
emoving the OCTO-PLUS from the recent trials’ analysis,
adial failures were found in 12 (1.9%) of 640 subjects and
emoral failures in 4 (0.7%) of 549 subjects (OR 2.16, CI
5% 0.74 to 6.34, p  0.16).
Possibly, this very interesting trend occurred because of
n evident improvement of all the materials, properly
edicated to the transradial approach. Indeed, new hydro-
hilic sheaths have been developed to reduce the incidence
f radial artery spasm (33). Moreover, different kinds of
harmacologic cocktails have been investigated to reduce
he occurrence of arterial spasm (34,35). Furthermore, novel
uiding catheters have been progressively used through the
ears, so that coronary engagement and balloon or stent
elivery were greatly simplified (36,37). However, the most
mportant improvement was that regarding operator skill. In
act, there is clear evidence in all the examined trials that a
earning curve is essential. Achieving access to the radial
rtery is technically more challenging and time-consuming
han gaining femoral access, but when the right skills are
rasped, the technique is much easier and reliable. Indeed,
n our meta-analysis, no statistically significant difference
as present in terms of procedural time, despite a strongly
ignificant heterogeneity among studies. Furthermore, the
rial with the largest number of patients (24) showed that
rocedural time for transradial PTCA was longer than that
or the transfemoral approach at an interim analysis, but at
he end of the trial, it was similar in the two techniques,
eflecting the completion of a learning curve. Moreover, in
he methods section of some trials, which reported the
umber of previous procedures performed via the radial
rtery, it is evident that trials conducted by experienced
perators (e.g., more than 1,000 procedures performed via
he transradial access before study commencement) (27)
howed much lower failure rates than trials in which
perators had only limited previous experience in transradial
oronary angiography or intervention (23). However, pro-
edural complexity of the transradial approach is still evident
nd underlined by fluoroscopy time, which was significantly
min longer with respect to femoral access.
OR (95% CI)
CE Entry Site Complications Procedural Failure
57–1.43) 0.18 (0.09–0.38) 3.29 (2.22–4.88)
18–1.24) 0.22 (0.09–0.59) 2.53 (1.14–5.61)
66–1.96) 0.16 (0.04–0.54) 5.17 (1.37–19.55)
57–1.57) 0.16 (0.06–0.41) 2.69 (0.91–7.92)
17–2.93) 0.29 (0.07–1.12) 5.19 (2.59–10.38)
64–1.88) 0.15 (0.05–0.46) 4.08 (1.46–11.41)
o; PCI  percutaneous coronary intervention.MA
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July 21, 2004:349–56 Radial Versus Femoral Coronary Procedures: Meta-Analysisomplications in the transradial group is remarkable, with
nly one arteriovenous fistula detected at one-month
ollow-up visit in one trial (23), perforation of the
rachial artery, requiring surgery, in another study (28),
nd one hematoma 3 cm that required prolonged
ospitalization in a third trial (31). The two other local
omplications occurred in patients who were randomized
o the radial approach, but later underwent coronary
rocedures from the femoral access, due to crossover (31).
n the transfemoral group, the percentage of complica-
ions was instead much higher, around 2.8%, including
seudo-aneurysms, arteriovenous fistulas, major bleed-
ngs, or large hematomas, sometimes requiring vascular
urgery or blood transfusion and significantly prolonging
he hospital stay. The radial artery is indeed superficial,
nd it may be easily compressed, achieving adequate
emostasis without “active” manual compression, but
nly with a “passive” pressure device or bandage, reducing
lso the workload of nursing and medical staff. Con-
ersely, transfemoral procedures are constantly burdened
y a number of local complications that even closure
evices cannot completely avoid (38,39). With the tech-
ologic improvements in these devices and increasing
xperience regarding their use, it should be interesting to
erform a direct randomized comparison of coronary
rocedures via radial versus femoral access with a closure
evice. To our knowledge, only two nonrandomized
tudies on this comparison have been published (40,41),
nd they yielded conflicting results, mainly due to a
ifferent completion of a learning curve in both proce-
ures. Another pertinent randomized study was recently
resented as an abstract (22), but the results are still
npublished and the data presented in the abstract are
nsufficient to achieve definitive conclusions.
nternal and external validity. Overall, the results of this
eta-analysis may be extrapolated to the majority of
atients undergoing coronary procedures, as indeed all
he clinical settings have been evaluated, ranging from
lective diagnostic catheterization to elective PTCA or
tenting to urgent PCI. In fact, these data have been also
onfirmed by several observational registries or retrospec-
ive studies, showing the radial approach to be safe and
easible in a large part of clinical practice (42– 44) and
lso in the case of aggressive pharmacologic treatments
uch as glycoprotein IIb/IIIa inhibitors (8) and oral
nticoagulants (45). In addition, the randomized to
creened ratio of patients enrolled was quite high
42%), and the main reasons for exclusion were prin-
ipally related to the presence of unstable symptoms,
hen an elective procedure was planned, or to the
lanned utilization of a device different from the one
onsidered in the study. The only exclusion criterion
trictly related to the access site, which can limit the use
f the transradial technique in daily clinical practice, was
n abnormal Allen test. Indeed, one of the major pitfalls
f transradial access is radial artery occlusion due tohrombosis. Its incidence ranged from 3% to 6% in the
tudies that planned a Doppler ultrasound examination of
he radial artery after the procedure (10,23,24), whereas a
oss of radial pulse was present in 0% to 9% of patients in
he other trials. No clinical sequelae were signaled after
cclusion of the radial artery.
Another issue is regarding the utilization of devices
equiring catheters with a larger inner diameter (7-F to 8-F
r more). No large-scale trials have been conducted, but
ome studies have shown the feasibility of 7-F to 8-F
ransradial procedures (46,47) in selected patients by expe-
ienced operators. Of course, these are pioneering reports,
nd further evaluation is needed with large-scale trials, but
echnologic improvements associated with increased opera-
or skills may lead to the utilization of transradial access in
lways more challenging situations without significant harm
o patients (48).
tudy limitations. Among the potential limitations of this
eta-analysis, which are well known and have been already
eported (15), two trials could not be included because the
uthors did not provide detailed data. Moreover, procedural
nd fluoroscopy time, length of stay, and cost analyses
howed substantial statistical heterogeneity, casting a
hadow of caution on the results and interpretation of these
omprehensive pooled effect estimates. Finally, data abstrac-
ion and quality assessment were done by independent
eviewers, but with for any divergencies, resolution was
ade by consensus. Thus, the inter-operator agreement
ould not be quantitatively assessed.
onclusions. This meta-analysis shows that the transradial
pproach for coronary procedures is a safe technique and
ields clinical results similar to transfemoral access. Indeed,
he radial approach virtually abolishes vascular entry site
omplications and permits a wide range of diagnostic and
herapeutic interventions. Nonetheless, technical challenges
ay impose crossover to another approach, with a rate of
bout 1 in 14. These findings thus support the radial
pproach as an interesting choice in a broad range of
atients, provided that experienced operators, state-of-the-
rt materials, and willingness to crossover to the femoral
pproach (“always prep a groin!”) are available.
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